ArticleClinics (Sao Paulo, Brazil)
Predicting readmission rates in critically ill heart failure patients during a 90-day vulnerable phase using interpretable machine learning models.
Article in Clinics (Sao Paulo, Brazil). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Yiqi Fumai Lyophilized Injection for Improving Exercise Tolerance in Chronic Heart Failure: Protocol for a Prospective Cohort Study.JMIR research protocols · 2026Article
- Atherogenic index of plasma and risk of acute kidney injury in critically ill patients: a multi-cohort study with machine learning and SHAP analysis.Renal failure · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe readmission rate of critically ill Heart Failure (HF) patients remains high during the vulnerable phase. However, predictive models based on more comprehensive comorbidities and medication histories are lacking. This study aims to extract these factors to develop interpretable models for predicting readmission risk.
methodsThe authors recruited critically ill HF patients from the MIMIC-IV database (as training and internal validation cohorts) as well as from the MIMIC-III database (as external validation cohorts). Four models, including Neural Multitasking Logistic Regression (NMTLR) were constructed and evaluated. Furthermore, Shapley Additive Explanations (SHAP) interpreted feature importance, simplifying the optimal model based on variable importance.
resultsA total of 12,126 patients were included in this study. Among four predictive models, the NMTLR model demonstrated the best predictive performance with the Area Under the Curve (AUC) of 0.752 (internal) and 0.785 (external), with the C-index of 0.7408 (internal) and 0.7724 (external), and with the mean cumulative/dynamic Area Under the Curve (mean AUC) score of 0.747 (internal) and 0.763 (external). Moreover, the Integrated Brier Score (IBS) of the NMTLR model was 0.062 (internal) and 0.043 (external). The SHAP analysis showed over one-third of the top 20 features in the NMTLR model were comorbidities and medications, including a newly relevant drug named psychoanaleptics. Furthermore, the compact NMTLR model also performed well.
conclusionDespite the limited representation of modern HF medications, both the full and compact NMTLR models are useful for predicting HF readmission. Additionally, psychoanaleptics might be a new predictor of readmission, warranting increased clinical attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.